| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
9 companies
Opaleye Management Inc. serves as a 10% Owner at OCUL and has filed Form 4s across 9 companies. Across recent SEC filings that breaks down to 230 buys and 102 sells. Those positions are worth an estimated $128.4M at current prices.
Historically, Opaleye Management Inc.'s trades have earned a middling insider score of 60/100 across 182 rated trades. Over a 12-month horizon, 45.4% of those trades were profitable, with an average 12-month return of +3.5%.
The biggest single holding is OCUL (~$45.2M) as 10% Owner. Net of sales, the recent Form 4 record there shows accumulation of 35,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 22, 2022 | TELA Tela Bio, Inc. | 10% Owner | Buy | 5,200 | $8.02 | $41,709.20 | +0.3% | +7.0% | +33.5% | |
| Jul 21, 2022 | TELA Tela Bio, Inc. | 10% Owner | Buy | 10,333 | $8.03 | $83,010.12 | +0.6% | +5.5% | +32.3% | |
| Jul 20, 2022 | TELA Tela Bio, Inc. | 10% Owner | Buy | 5,100 | $8.08 | $41,191.68 | +0.3% | +6.1% | +28.0% | |
| Jul 1, 2022 | TELA Tela Bio, Inc. | 10% Owner | Buy | 200 | $7.00 | $1,400.00 | +0.2% | +12.9% | +37.6% | |
| Jun 30, 2022 | TELA Tela Bio, Inc. | 10% Owner | Buy | 3,567 | $7.00 | $24,968.98 | +0.1% | +21.0% | +44.5% | |
| Jun 22, 2022 | TELA Tela Bio, Inc. | 10% Owner | Buy | 2,400 | $6.99 | $16,776.00 | +0.1% | +29.2% | +66.9% | |
| Jun 22, 2022 | TELA Tela Bio, Inc. | 10% Owner | Buy | 52,400 | $6.50 | $340,573.80 | +3.3% | +29.2% | +66.9% | |
| Jun 10, 2022 | TELA Tela Bio, Inc. | 10% Owner | Buy | 27,500 | $5.60 | $154,066.00 | +1.8% | +55.5% | +92.3% | |
| Apr 13, 2022 | HROW Harrow, Inc. | 10% Owner | Buy | 41,389 | $6.75 | $279,502.30 | +0.6% | +3.8% | +226.4% | |
| Apr 8, 2022 | TARA Protara Therapeutics, Inc. | 10% Owner | Buy | 10,136 | $4.78 | $48,486.88 | +0.2% | -34.7% | -41.4% |